These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 164974)

  • 1. Plasma immunoreactive melanotrophic hormones in patients on maintenance haemodialysis.
    Gilkes JJ; Eady RA; Rees LH; Munro DD; Moorhead JF
    Br Med J; 1975 Mar; 1(5959):656-7. PubMed ID: 164974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure.
    Smith AG; Shuster S; Comaish JS; Plummer NA; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1975 Mar; 1(5959):658-9. PubMed ID: 1125653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH.
    Bertagna X; Donnadieu M; Idatte JM; Girard F
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1179-86. PubMed ID: 201658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotrophic and melanotrophic functions in congenital adrenal hyperplasia.
    Lombardi G; Oliver Ch; Lupoli G; Minozzi M
    Acta Endocrinol (Copenh); 1977 May; 85(1):118-25. PubMed ID: 16424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pituitary melanotrophic hormones.
    Gilkes JJ
    Br J Dermatol; 1974 Sep; 91(3):353-5. PubMed ID: 4373019
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG; Shuster S; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1976 Apr; 1(6014):874-6. PubMed ID: 769907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Plasma immunoreactive 'beta-melanocyte-stimulating hormone' in patients on maintenance dialysis.
    Gilkes JJ; Eady RA; Rees LH; Munro DD; Moorhead JF
    J Endocrinol; 1975 Jun; 65(3):48P. PubMed ID: 168301
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal responsiveness during and after intermittent haemodialysis.
    Grekas D; Tourkantonis A; Pharmakiotis A
    Clin Exp Dial Apheresis; 1983; 7(3):197-205. PubMed ID: 6323072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
    Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O
    Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of N-terminal (1-76) of human proopiomelanocortin in human plasma: correlation with adrenocorticotropin.
    Chan JS; Seidah NG; Chrétien M
    J Clin Endocrinol Metab; 1983 Apr; 56(4):791-6. PubMed ID: 6300165
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioimmunological determination of plasma ACTH and beta-MSH in congenital adrenal gland hyperplasia].
    Lombardi G; Faggiano M; Lupoli G; Minozzi M
    Minerva Pediatr; 1976 Jun; 28(22):1450-3. PubMed ID: 181667
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of a radioimmunoassay for beta-MSH-related peptides (lipotrophins) in human plasma.
    Gray CE; Ratcliffe JG
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):163-72. PubMed ID: 218751
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoreactive ACTH and gamma-MSH in rat plasma during early stages of adrenal regeneration.
    Alfano J; Dressler LG; Brownie AC
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E471-4. PubMed ID: 2984942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary.
    Usategui R; Oliver C; Vaudry H; Lombardi G; Rozenberg I; Mourre AM
    Endocrinology; 1976 Jan; 98(1):189-96. PubMed ID: 174889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma corticotrophin levels in addison-schilder's disease.
    Rees LH; Grant DB; Wilson J
    Br Med J; 1975 Jul; 3(5977):201-2. PubMed ID: 167903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ACTH and melanocyte-stimulating hormone in nail pigmentation.
    Arakawa S; Takamatsu T; Imashuku S; Kusunoki T
    Arch Dis Child; 1978 Mar; 53(3):249-50. PubMed ID: 206211
    [No Abstract]   [Full Text] [Related]  

  • 18. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating opioid peptides in chronic renal failure: acute effect of dialysis treatment].
    Petraglia F; Facchinetti F; De Leo M; Parrini D; De Leo V; Verzetti G; De Luca S; Genazzani AR
    Boll Soc Ital Biol Sper; 1982 May; 58(9):578-84. PubMed ID: 6282295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
    Peterson ME; Kemppainen RJ; Orth DN
    Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.